Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

BACKGROUND: Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence, ET-resistant (ET-R) HR+ BCa presents a therapeutic chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahnassy, Shaymaa, Thangavel, Hariprasad, Quttina, Maram, Khan, Ashfia Fatima, Dhanyalayam, Dhanya, Ritho, Joan, Karami, Samaneh, Ren, Jing, Bawa-Khalfe, Tasneem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501670/
https://www.ncbi.nlm.nih.gov/pubmed/32948192
http://dx.doi.org/10.1186/s12964-020-00649-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501670/
https://www.ncbi.nlm.nih.gov/pubmed/32948192
http://dx.doi.org/10.1186/s12964-020-00649-z

Ejemplares similares